Healthcare provider profile · identity verified

Amy M Byerly, M.D.

Family Practice · LOUISVILLE, KY · NPI 1245296151

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	149
Levothyroxine Sodium	Levothyroxine Sodium	418	116
Amlodipine Besylate	Amlodipine Besylate	316	91
Lisinopril	Lisinopril	312	87
Pantoprazole Sodium	Pantoprazole Sodium	256	68
Gabapentin	Gabapentin	240	47
Omeprazole	Omeprazole	209	58
Metoprolol Succinate	Metoprolol Succinate	193	57
Alprazolam	Alprazolam	186	27
Escitalopram Oxalate	Escitalopram Oxalate	185	46
Albuterol Sulfate Hfa	Albuterol Sulfate	171	52
Hydrochlorothiazide	Hydrochlorothiazide	166	46
Furosemide	Furosemide	163	46
Clonazepam	Clonazepam	160	21
Rosuvastatin Calcium	Rosuvastatin Calcium	157	43
Losartan Potassium	Losartan Potassium	154	41
Metformin Hcl	Metformin Hcl	143	48
Montelukast Sodium	Montelukast Sodium	132	37
Trazodone Hcl	Trazodone Hcl	128	35
Sertraline Hcl	Sertraline Hcl	124	34
Lorazepam	Lorazepam	118	19
Metoprolol Tartrate	Metoprolol Tartrate	117	31
Simvastatin	Simvastatin	114	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	20
Prednisone	Prednisone	111	61
Fluticasone Propionate	Fluticasone Propionate	109	36
Pravastatin Sodium	Pravastatin Sodium	100	26
Synthroid	Levothyroxine Sodium	100	22
Tramadol Hcl	Tramadol Hcl	98	18
Diclofenac Sodium	Diclofenac Sodium	92	28
Zolpidem Tartrate	Zolpidem Tartrate	91	16
Famotidine	Famotidine	86	20
Bupropion Xl	Bupropion Hcl	84	28
Potassium Chloride	Potassium Chloride	82	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	14
Eliquis	Apixaban	80	16
Allopurinol	Allopurinol	75	18
Carvedilol	Carvedilol	72	21
Citalopram Hbr	Citalopram Hydrobromide	72	18
Glipizide Er	Glipizide	72	17
Meloxicam	Meloxicam	70	22
Metformin Hcl Er	Metformin Hcl	68	19
Tamsulosin Hcl	Tamsulosin Hcl	67	21
Glimepiride	Glimepiride	66	21
Benazepril Hcl	Benazepril Hcl	64	17
Clopidogrel	Clopidogrel Bisulfate	64	21
Duloxetine Hcl	Duloxetine Hcl	64	18
Atenolol	Atenolol	63	17
Buspirone Hcl	Buspirone Hcl	63	18
Hydroxyzine Hcl	Hydroxyzine Hcl	62	22
Baclofen	Baclofen	60	17
Fluoxetine Hcl	Fluoxetine Hcl	59	16
Promethazine Hcl	Promethazine Hcl	59	15
Pioglitazone Hcl	Pioglitazone Hcl	58	19
Tizanidine Hcl	Tizanidine Hcl	55	16
Doxycycline Hyclate	Doxycycline Hyclate	49	39
Venlafaxine Hcl Er	Venlafaxine Hcl	49	15
Ondansetron Odt	Ondansetron	48	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	11
Pregabalin	Pregabalin	46	suppressed
Mirtazapine	Mirtazapine	45	16
Methocarbamol	Methocarbamol	44	14
Esomeprazole Magnesium	Esomeprazole Magnesium	42	13
Ibuprofen	Ibuprofen	42	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	12
Quetiapine Fumarate	Quetiapine Fumarate	42	12
Fluconazole	Fluconazole	40	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Klor-Con M20	Potassium Chloride	38	suppressed
Spironolactone	Spironolactone	38	12
Alendronate Sodium	Alendronate Sodium	37	14
Ondansetron Hcl	Ondansetron Hcl	37	17
Ropinirole Hcl	Ropinirole Hcl	36	11
Cephalexin	Cephalexin	35	27
Doxepin Hcl	Doxepin Hcl	35	suppressed
Azithromycin	Azithromycin	34	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	13
Ezetimibe	Ezetimibe	34	12
Ozempic	Semaglutide	34	12
Trulicity	Dulaglutide	34	suppressed
Bumetanide	Bumetanide	32	suppressed
Estradiol	Estradiol	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Linzess	Linaclotide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	12
Premarin	Estrogens, Conjugated	30	suppressed
Torsemide	Torsemide	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Mupirocin	Mupirocin	29	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Topiramate	Topiramate	28	11
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	22
Amitriptyline Hcl	Amitriptyline Hcl	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	18
Colestipol Hcl	Colestipol Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	17
Glipizide	Glipizide	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Temazepam	Temazepam	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Naproxen	Naproxen	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Cefdinir	Cefdinir	19	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Nystatin	Nystatin	17	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Niacin Er	Niacin	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Seroquel Xr	Quetiapine Fumarate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Edecrin	Ethacrynic Acid	14	suppressed
Finasteride	Finasteride	14	suppressed
Geodon	Ziprasidone Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Almotriptan Malate	Almotriptan Malate	12	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	12	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lamictal	Lamotrigine	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Etodolac	Etodolac	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error